Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven M. Devine, MD
Ohio State University Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center
Boston, Massachusetts, United States
- Dana-Farber/harvard Cancer Center at Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Monter Cancer Center of the North Shore-Lij Health System
Lake Success, New York, United States
- Ccop - North Shore University Hospital
Manhasset, New York, United States
- Don Monti Comprehensive Cancer Center at North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- New York Weill Cornell Cancer Center at Cornell University
New York, New York, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2004
- Primary completion
- 31 Dec 2013
- Completion
- 15 Jun 2016
- Last update posted
- 12 Jun 2018
- Registered enrollment
- 121
- Registry id
- NCT00070135
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.